1. Home
  2. CABA vs DHX Comparison

CABA vs DHX Comparison

Compare CABA & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CABA
  • DHX
  • Stock Information
  • Founded
  • CABA 2017
  • DHX 1991
  • Country
  • CABA United States
  • DHX United States
  • Employees
  • CABA N/A
  • DHX N/A
  • Industry
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • DHX Business Services
  • Sector
  • CABA Health Care
  • DHX Consumer Discretionary
  • Exchange
  • CABA Nasdaq
  • DHX Nasdaq
  • Market Cap
  • CABA 118.8M
  • DHX 136.8M
  • IPO Year
  • CABA 2019
  • DHX 2007
  • Fundamental
  • Price
  • CABA $2.06
  • DHX $2.62
  • Analyst Decision
  • CABA Strong Buy
  • DHX Strong Buy
  • Analyst Count
  • CABA 8
  • DHX 2
  • Target Price
  • CABA $26.13
  • DHX $5.25
  • AVG Volume (30 Days)
  • CABA 1.4M
  • DHX 237.9K
  • Earning Date
  • CABA 03-20-2025
  • DHX 02-05-2025
  • Dividend Yield
  • CABA N/A
  • DHX N/A
  • EPS Growth
  • CABA N/A
  • DHX N/A
  • EPS
  • CABA N/A
  • DHX 0.01
  • Revenue
  • CABA N/A
  • DHX $141,926,000.00
  • Revenue This Year
  • CABA N/A
  • DHX N/A
  • Revenue Next Year
  • CABA N/A
  • DHX $1.64
  • P/E Ratio
  • CABA N/A
  • DHX $478.95
  • Revenue Growth
  • CABA N/A
  • DHX N/A
  • 52 Week Low
  • CABA $1.76
  • DHX $1.45
  • 52 Week High
  • CABA $24.85
  • DHX $3.32
  • Technical
  • Relative Strength Index (RSI)
  • CABA 38.28
  • DHX 47.12
  • Support Level
  • CABA $2.03
  • DHX $2.92
  • Resistance Level
  • CABA $2.90
  • DHX $3.32
  • Average True Range (ATR)
  • CABA 0.24
  • DHX 0.26
  • MACD
  • CABA -0.04
  • DHX -0.06
  • Stochastic Oscillator
  • CABA 4.00
  • DHX 15.66

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and ClearanceJobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on our websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

Share on Social Networks: